{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:30:40Z","timestamp":1794317440735,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011087","name":"Society of Interventional Radiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jhepr.2026.102042","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:22:01Z","timestamp":1790148121000},"page":"102042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling liver cancer molecular and histological features by CRISPR editing of porcine hepatocytes"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-298X","authenticated-orcid":false,"given":"Lobna","family":"Elkhadragy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4565-6161","authenticated-orcid":false,"given":"Olayinka G.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn C.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9199-8084","authenticated-orcid":false,"given":"Luke N.","family":"Redlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-0179","authenticated-orcid":false,"given":"Isadora","family":"Andre Rosa Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3593-7202","authenticated-orcid":false,"given":"Jonathan P.","family":"Samuelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Lujambio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7293-8642","authenticated-orcid":false,"given":"Kyle M.","family":"Schachtschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.102042_bib1","first-page":"209","article-title":"Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhepr.2026.102042_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2026.102042_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Electronic address wbe, cancer genome atlas Research N. Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2026.102042_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng.3547","article-title":"Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer","volume":"48","author":"Fujimoto","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2026.102042_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2026.102042_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2013.03.013","article-title":"Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types","volume":"145","author":"Holczbauer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102042_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111643","article-title":"In vitro transformation of primary human hepatocytes: epigenetic changes and stemness properties","volume":"384","author":"Pez","year":"2019","journal-title":"Exp Cel Res"},{"key":"10.1016\/j.jhepr.2026.102042_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41556-019-0359-5","article-title":"Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes","volume":"21","author":"Sun","year":"2019","journal-title":"Nat Cel Biol"},{"key":"10.1016\/j.jhepr.2026.102042_bib9","article-title":"Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.102042_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrc1235","article-title":"Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice","volume":"3","author":"Rangarajan","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2026.102042_bib11","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/0008-5472.CAN-11-2786","article-title":"Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes","volume":"72","author":"Singh","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102042_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00330-008-1263-8","article-title":"Animal models of cancer in interventional radiology","volume":"19","author":"Aravalli","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhepr.2026.102042_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2019.01.027","article-title":"Combined locoregional-immunotherapy for liver cancer","volume":"70","author":"Greten","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/genes11060670","article-title":"Application of genetically engineered pigs in Biomedical Research","volume":"11","author":"Hryhorowicz","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jhepr.2026.102042_bib16","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.18632\/oncotarget.27647","article-title":"Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation","volume":"11","author":"Gaba","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2026.102042_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvir.2024.11.014","article-title":"Pressure-enabled drug Delivery significantly Increases Intra-arterial Delivery of embolic Microspheres to liver tumors in a porcine model","volume":"36","author":"Jaroch","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2026.102042_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jvir.2020.09.011","article-title":"Transarterial embolization of liver cancer in a transgenic pig model","volume":"32","author":"Nurili","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2026.102042_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2144\/btn-2020-0119","article-title":"Generation of genetically tailored porcine liver cancer cells by CRISPR\/Cas9 editing","volume":"70","author":"Elkhadragy","year":"2021","journal-title":"Biotechniques"},{"key":"10.1016\/j.jhepr.2026.102042_bib20","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.052079","article-title":"Development of a genetically tailored implantation hepatocellular carcinoma model in Oncopigs by somatic cell CRISPR editing","volume":"18","author":"Elkhadragy","year":"2025","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhepr.2026.102042_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.904031","article-title":"Effect of CRISPR knockout of AXIN1 or ARID1A on proliferation and Migration of porcine hepatocellular carcinoma","volume":"12","author":"Elkhadragy","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2026.102042_bib22","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102042_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/HEP.0000000000000513","article-title":"Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making","volume":"81","author":"Dhanasekaran","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102042_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhepr.2026.102042_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102042_bib26","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1053\/j.gastro.2020.08.015","article-title":"Cooperation between distinct cancer driver genes underlies inter-tumor heterogeneity in hepatocellular carcinoma","volume":"159","author":"Molina-Sanchez","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102042_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib28","article-title":"Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening","volume":"4","author":"Wang","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhepr.2026.102042_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2008.09.061","article-title":"An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer","volume":"135","author":"Zender","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2026.102042_bib30","article-title":"Primary hepatocyte isolation and cultures: technical Aspects, Challenges and advancements","volume":"10","author":"Kaur","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.jhepr.2026.102042_bib31","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.7150\/jca.44697","article-title":"CK19-positive hepatocellular carcinoma is a characteristic subtype","volume":"11","author":"Zhuo","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jhepr.2026.102042_bib32","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.18632\/aging.102969","article-title":"Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis","volume":"12","author":"Hua","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhepr.2026.102042_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.608017","article-title":"Identification of Core genes related to progression and prognosis of hepatocellular carcinoma and small-Molecule drug Predication","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jhepr.2026.102042_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284135","article-title":"Tissue-engineered vocal fold replacement in swine: Methods for functional and structural analysis","volume":"18","author":"Schlegel","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.102042_bib35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102042_bib36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1209892","article-title":"Genetic induction of tumorigenesis in swine","volume":"26","author":"Adam","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jhepr.2026.102042_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn5683","article-title":"Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes","volume":"8","author":"Tang","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhepr.2026.102042_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2023.02.039","article-title":"MYC determines lineage commitment in KRAS-driven primary liver cancer development","volume":"79","author":"D'Artista","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104786","article-title":"Targeting c-MYC has a key role in hepatocellular carcinoma therapy","volume":"213","author":"Dai","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jhepr.2026.102042_bib40","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-08-3357","article-title":"Central role of c-Myc during malignant conversion in human hepatocarcinogenesis","volume":"69","author":"Kaposi-Novak","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102042_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jhep.2013.09.024","article-title":"Role of Myc in hepatocellular proliferation and hepatocarcinogenesis","volume":"60","author":"Qu","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/genes8040123","article-title":"c-MYC-Making liver Sick: role of c-MYC in hepatic cell function, Homeostasis and disease","volume":"8","author":"Zheng","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jhepr.2026.102042_bib43","article-title":"Distinct metabolic phenotype renders beta-catenin mutant hepatocellular carcinoma susceptible to treatment-induced ischemia","author":"Weinfurtner","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.jhepr.2026.102042_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32010051","article-title":"TP53 mutation Predicts Worse survival and Earlier local progression in patients with hepatocellular carcinoma treated with Transarterial embolization","volume":"32","author":"Zhao","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhepr.2026.102042_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871829","article-title":"Rabbit VX2 liver tumor model: a Review of clinical, biology, Histology, and tumor microenvironment characteristics","volume":"12","author":"Pascale","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2026.102042_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000446074","article-title":"Validation of a preclinical model of Diethylnitrosamine-induced hepatic Neoplasia in Yucatan Miniature pigs","volume":"91","author":"Mitchell","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.jhepr.2026.102042_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-animal-111523-102125","article-title":"Translational relevance and future integration of the Oncopig cancer model in preclinical Applications","volume":"13","author":"Elkhadragy","year":"2025","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.jhepr.2026.102042_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2022.02.023","article-title":"Deleting the beta-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth","volume":"77","author":"Loesch","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102042_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/path.6054","article-title":"CRISPR-induced exon skipping of beta-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer","volume":"259","author":"Mou","year":"2023","journal-title":"J Pathol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:19:18Z","timestamp":1794316758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926003137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2589555926003137"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102042","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling liver cancer molecular and histological features by CRISPR editing of porcine hepatocytes","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102042"}}